Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Restriction of big hearts by a small RNA.

Literature DB >> 21293005

Restriction of big hearts by a small RNA.

Haipeng Sun, Yibin Wang.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2011 PMID： 21293005 PMCID： PMC3074488 DOI： 10.1161/CIRCRESAHA.110.239426

Source DB: PubMed Journal: Circ Res ISSN： 0009-7330 Impact factor: 17.367

× No keyword cloud information.

30 in total

1. Control of stress-dependent cardiac growth and gene expression by a microRNA.

Authors: Eva van Rooij; Lillian B Sutherland; Xiaoxia Qi; James A Richardson; Joseph Hill; Eric N Olson
Journal: Science Date: 2007-03-22 Impact factor: 47.728

2. Thioredoxin1 upregulates mitochondrial proteins related to oxidative phosphorylation and TCA cycle in the heart.

Authors: Tetsuro Ago; Ijen Yeh; Mitsutaka Yamamoto; Martina Schinke-Braun; Jeffrey A Brown; Bin Tian; Junichi Sadoshima
Journal: Antioxid Redox Signal Date: 2006 Sep-Oct Impact factor: 8.401

3. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Authors: Eva van Rooij; Lillian B Sutherland; Ning Liu; Andrew H Williams; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal: Proc Natl Acad Sci U S A Date: 2006-11-15 Impact factor: 11.205

Review 4. Application of recombinant thioredoxin1 for treatment of heart disease.

Authors: Shouji Matsushima; Daniela Zablocki; Junichi Sadoshima
Journal: J Mol Cell Cardiol Date: 2010-10-16 Impact factor: 5.000

5. MicroRNAs play an essential role in the development of cardiac hypertrophy.

Authors: Danish Sayed; Chull Hong; Ieng-Yi Chen; Jacqueline Lypowy; Maha Abdellatif
Journal: Circ Res Date: 2007-01-18 Impact factor: 17.367

6. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy.

Authors: Mitsutaka Yamamoto; Guiping Yang; Chull Hong; Jing Liu; Eric Holle; Xianzhong Yu; Thomas Wagner; Stephen F Vatner; Junichi Sadoshima
Journal: J Clin Invest Date: 2003-11 Impact factor: 14.808

7. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2.

Authors: Yong Zhao; Joshua F Ransom; Ankang Li; Vasanth Vedantham; Morgan von Drehle; Alecia N Muth; Takatoshi Tsuchihashi; Michael T McManus; Robert J Schwartz; Deepak Srivastava
Journal: Cell Date: 2007-03-29 Impact factor: 41.582

8. MicroRNA-133 controls cardiac hypertrophy.

Authors: Alessandra Carè; Daniele Catalucci; Federica Felicetti; Désirée Bonci; Antonio Addario; Paolo Gallo; Marie-Louise Bang; Patrizia Segnalini; Yusu Gu; Nancy D Dalton; Leonardo Elia; Michael V G Latronico; Morten Høydal; Camillo Autore; Matteo A Russo; Gerald W Dorn; Oyvind Ellingsen; Pilar Ruiz-Lozano; Kirk L Peterson; Carlo M Croce; Cesare Peschle; Gianluigi Condorelli
Journal: Nat Med Date: 2007-04-29 Impact factor: 53.440

Restriction of big hearts by a small RNA.

1. Control of stress-dependent cardiac growth and gene expression by a microRNA.

2. Thioredoxin1 upregulates mitochondrial proteins related to oxidative phosphorylation and TCA cycle in the heart.

3. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Review 4. Application of recombinant thioredoxin1 for treatment of heart disease.

5. MicroRNAs play an essential role in the development of cardiac hypertrophy.

6. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy.

7. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2.

8. MicroRNA-133 controls cardiac hypertrophy.

Review 9. Thioredoxin1 as a negative regulator of cardiac hypertrophy.

Review 1. Cardiac myocyte-fibroblast interactions and the coronary vasculature.

2. Nuclear miRNA regulates the mitochondrial genome in the heart.

3. MicroRNAs micromanage themselves.

4. Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease.

5. MicroRNA-181c targets Bcl-2 and regulates mitochondrial morphology in myocardial cells.

Review 6. Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells.